Related Experiment Video
Updated: Oct 11, 2025

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
Tumor-related Molecular Regulatory Mechanisms of Long Non-coding RNA RMST: Recent Evidence
Xuhui Chen1, Kai Liu1, Wen Xu1
1College of Medical Science, China Three Gorges University, Yichang 443002, China.
Background:
Long non-coding RNA rhabdomyosarcoma 2-associated transcript (LncRNA RMST) can affect every aspect of tumor progressions, such as proliferation, translocation, and apoptosis. As a result, RMST can be used as an attractive biomarker for early diagnosis and clinical therapies of different disease states. This article aims to review pathophysiological functions, molecular mechanisms as well as promising biotherapies of RMST in multiple tumors.
Methods:
Through the systematic induction and summary of 46 papers published in PubMed concerning this study, the molecular mechanisms of RMST in all kinds of tumors have been reviewed.
Results:
LncRNA RMST is a tumor-related regulatory mediator, aberrantly expressed in diverse tumors, including medullary thyroid cancer, hepatocellular carcinoma, endometrial carcinoma, colon cancer, pancreatic cancer, glioma, Wilm's tumor, and breast cancer. Furthermore, as a mechanismbased player, RMST probably guides the translation and post-translation modification, containing DNA methylation and SUMOylation. It is capable of regulating distinct tumor cells and stem cells of biological behaviors via various molecular pathways.
Conclusion:
LncRNA RMST, potentially as an original therapeutic target, is valuable in the occurrence, development, and apoptosis of different tumors.
Insights
Long non-coding RNA rhabdomyosarcoma 2-associated transcript (RMST) is a key regulator in various cancers. This review explores RMST's functions, mechanisms, and therapeutic potential in tumor development and apoptosis.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Long non-coding RNA rhabdomyosarcoma 2-associated transcript (LncRNA RMST) influences tumor progression, including proliferation and apoptosis.
- RMST serves as a potential biomarker for early cancer diagnosis and therapeutic strategies.
Purpose of the Study:
- To review the pathophysiological functions of LncRNA RMST.
- To elucidate the molecular mechanisms underlying RMST's role in multiple tumors.
- To explore promising biotherapies targeting RMST.
Main Methods:
- Systematic literature review of 46 PubMed-published papers.
- Analysis of molecular mechanisms of RMST in various tumor types.
Main Results:
- LncRNA RMST is aberrantly expressed in diverse tumors such as thyroid, liver, endometrial, colon, pancreatic, glioma, Wilm's, and breast cancers.
- RMST regulates biological behaviors of tumor and stem cells via multiple molecular pathways, including DNA methylation and SUMOylation.
- RMST acts as a mechanism-based player, potentially guiding translation and post-translation modifications.
Conclusions:
- LncRNA RMST is a tumor-related regulatory mediator with significant implications in cancer.
- RMST holds potential as an original therapeutic target for cancer occurrence, development, and apoptosis.
Related Concept Videos
lncRNA - Long Non-coding RNAs
MicroRNAs
RNA Stability
Translational Regulation
Types of RNA
RNA Performs Diverse...
Non-LTR Retrotransposons
